Estadístiques de Olaparib monotherapy in advanced triple-negative breast cancer patients with homologous recombination deficiency and without germline mutations in BRCA1/2: The NOBROLA phase 2 study
Visites totals
| views | |
|---|---|
| Olaparib monotherapy in advanced triple-negative breast cancer patients with homologous recombination deficiency and without germline mutations in BRCA1/2: The NOBROLA phase 2 study | 8 |
Visites totals per mes
| views | |
|---|---|
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 8 |
| November 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| Cortes_bre_olap.pdf | 48 |
| Cortes_bre_olap.pdf | 3 |